These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 741652)

  • 1. Concanavalin A-mediated cell agglutinability induced by vaccinia virions.
    Mbuy G; Bubel HC
    Virology; 1978 Dec; 91(2):256-66. PubMed ID: 741652
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of vaccinia virion surface tubule protein as a virus specific cell surface antigen.
    Harry TO
    Arch Virol; 1978; 58(3):235-41. PubMed ID: 727948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinia virus proteins on the plasma membranes of infected cells. IV. Studies employing L cells infected with ultraviolet-irradiated vaccinia virions.
    Domber E; Holowczak JA
    Virology; 1986 Jul; 152(2):331-42. PubMed ID: 3487879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between agglutinability of concanavalin A and nucleic acid synthesis induced by polyoma virus].
    Barra Y; Meyer G
    C R Acad Hebd Seances Acad Sci D; 1975 Mar; 280(9):1205-8. PubMed ID: 172252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contact-mediated changes in cycloheximide-induced agglutinability of BHK cells.
    Logothetou H; Thompson JE
    Exp Cell Res; 1977 Feb; 104(2):434-9. PubMed ID: 837985
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of concanavalin A binding sites in rabbit kidney cells infected with vaccinia virus.
    Zarling JM; Tevethia SS
    Virology; 1971 Jul; 45(1):313-6. PubMed ID: 5165252
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased agglutinability and haemadsorption of Marek's disease HPRS line 1 lymphoblastoic cells after concanavalin A treatment.
    Benda V; Branny J
    Folia Biol (Praha); 1979; 25(5):288-92. PubMed ID: 231521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccinia virus proteins on the plasma membranes of infected cells. II. Expression of viral antigens and killing of infected cells by vaccinia virus-specific cytotoxic T cells.
    Mallon VR; Domber EA; Holowczak JA
    Virology; 1985 Aug; 145(1):1-23. PubMed ID: 3874471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concanavalin A induced agglutinability of the isolated cells of hamster melanotic and amelanotic melanomas.
    Kozłowska K; Zurawska-Czupa B; Bomirski A
    Arch Immunol Ther Exp (Warsz); 1980; 28(1):161-6. PubMed ID: 7416919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concanavalin A agglutinability of a temperature-sensitive mutant of Rous sarcoma virus.
    Miki T; Kuwata T
    J Gen Virol; 1976 Oct; 33(1):25-30. PubMed ID: 185327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concanavalin A-mediated agglutination of 3T3 cells after exposure to UV-irradiated herpes simplex virus.
    Taguchi F; Hara K; Nagaki D
    Microbiol Immunol; 1978; 22(10):597-608. PubMed ID: 216891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of agglutinability by alteration of the surface topography in mouse ascites tumor cells.
    Oppenheimer SB; Bales BL; Brenneman G; Knapp L; Lesin ES; Neri A; Pollock EG
    Exp Cell Res; 1977 Mar; 105(2):291-300. PubMed ID: 191266
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of neuraminidase on concanavalin A agglutination of erythrocytes: evidence for adsorption of neuraminidase to erythrocyte membrane.
    LaMont JT; Isselbacher KJ
    J Cell Physiol; 1977 Mar; 90(3):565-72. PubMed ID: 558203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface mobility of a bacterial R-form glycolipid mR595, after binding to rat cells, and its effect on the mobility of concanavalin A receptors.
    Brailovsky CA; Nigam VN; Pesant S
    Exp Cell Res; 1977 Oct; 109(2):389-95. PubMed ID: 913500
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of concanavalin A-induced agglutination of Novikoff tumor cells by cytochalasins and metabolic inhibitors. Role of cell-surface morphology and the distribution of concanavalin A receptors.
    Glenney JR; Hixson DC; Walborg EF
    Exp Cell Res; 1979 Feb; 118(2):353-64. PubMed ID: 761592
    [No Abstract]   [Full Text] [Related]  

  • 16. Agglutinability of Rous cells by concanavalin A: study with a temperature-sensitive RSV mutant and inhibitors of macromolecular synthesis.
    Biquard JM
    Intervirology; 1973; 1(3):220-3. PubMed ID: 4359762
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in antigenic properties of the p35 protein of vaccinia virus in various protein fractions of the virion with the use of monospecific antisera].
    Muravlev AI; Poryvaeva VA; Reshetnikov SS
    Mol Gen Mikrobiol Virusol; 1989 Sep; (9):3-7. PubMed ID: 2615775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of complement-enhanced neutralization of vaccinia virus virions by novel monoclonal antibodies raised against the vaccinia virus complement control protein.
    Isaacs SN; Argyropoulos E; Sfyroera G; Mohammad S; Lambris JD
    J Virol; 2003 Aug; 77(15):8256-62. PubMed ID: 12857894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of correlation between agglutinability, the surface distribution of con A and post-confluence inhibition of cell division in ten cell lines.
    Ukena TE; Goldman E; Benjamin TL; Karnovsky MJ
    Cell; 1976 Feb; 7(2):213-22. PubMed ID: 954079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increased immunogenicity of plasma membranes of BHK-cells infected by vaccinia virus].
    Bandlow G; Koszinowski U; Thomssen R
    Arch Gesamte Virusforsch; 1973; 40(1):63-71. PubMed ID: 4571171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.